Neurogene
NGNE
NGNE
96 hedge funds and large institutions have $342M invested in Neurogene in 2026 Q1 according to their latest regulatory filings, with 19 funds opening new positions, 43 increasing their positions, 16 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
2.39% more ownership
Funds ownership: 106.56% → 108.96% (+2.4%)
0% more capital invested
Capital invested by funds: $340M → $342M (+$1.62M)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Holders
96
Holding in Top 10
1
Calls
$3.4M
Puts
$833K
Top Buyers
| 1 | +$4.89M | |
| 2 | +$2.91M | |
| 3 | +$2.59M | |
| 4 |
CC
Casdin Capital
New York
|
+$2.42M |
| 5 |
Balyasny Asset Management
Chicago,
Illinois
|
+$2.13M |
Top Sellers
| 1 | -$4.02M | |
| 2 | -$1.66M | |
| 3 | -$1.05M | |
| 4 |
ACH
ArrowMark Colorado Holdings
Denver,
Colorado
|
-$1.02M |
| 5 |
TI
Trexquant Investment
Stamford,
Connecticut
|
-$892K |
